100
CurrentFee waivers in relation to the Medicines Repurposing Program
Part 9Transitional
Division 25Transitional provisions relating to the Therapeutic Goods Legislation Amendment (2024 Measures No. 2) Regulations 2024
100 Fee waivers in relation to the Medicines Repurposing Program
Subregulation 45(4AB) of these Regulations, as inserted by Part 1 of Schedule 1 to the amending regulations, applies in relation to an application made on or after the commencement of that Schedule.
This Act’s bill:Explanatory statement
Research tools for this sectionSubscription
The statute text is free to read above. View subscription options to unlock the case-law research tools for each provision.